Exploring genetic changes in brain tissue to understand Alzheimer's disease

Using long-range technologies as a multi-omic approach to understand Alzheimer’s disease in brain tissue

NIH-funded research University of Kentucky · NIH-10850701

This study is looking at the tiny changes in genes and RNA in brain tissue to better understand how Alzheimer's disease develops, which could help find new ways to diagnose and treat the condition for patients in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky NIH-funded
Lab location1 site (Lexington, United States)
Project IDNIH-10850701 on NIH RePORTER

What this research studies

This research aims to uncover the specific molecular changes that contribute to Alzheimer's disease by using advanced DNA mapping and sequencing techniques. By analyzing brain tissue, the study seeks to identify genetic variants and RNA modifications that may play a role in the disease's progression. This approach focuses on understanding the mechanisms behind Alzheimer's, which could lead to earlier diagnosis and targeted therapies. Patients may benefit from insights that could inform future treatment options and diagnostic tools.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those with early symptoms of cognitive decline.

Not a fit: Patients with advanced Alzheimer's disease or those without any familial or genetic risk factors for the condition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and more effective treatments for Alzheimer's disease.

How similar studies have performed: Previous research using similar genetic and molecular approaches has shown promise in understanding neurodegenerative diseases, suggesting potential for success in this study.

Where this research is happening

Lexington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.